Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Monsanto
Pharma
Bayer's new CEO Bill Anderson weighs structural change
In his first quarterly call since taking over as CEO, Anderson pointed to early 2024 as the period when the company could make structural changes.
Kevin Dunleavy
Aug 8, 2023 11:15am
Trade union resists potential Bayer breakup
Feb 13, 2023 11:05am
Investor pressures Bayer to separate crop and pharma units
Jan 17, 2023 8:30am
After years of investor flak, Bayer's reportedly seeking new CEO
Sep 13, 2022 2:49pm
Embattled CEO Baumann gets another investor vote of confidence
May 2, 2022 10:40am
ISS and Glass Lewis have thrown in their support for Bayer's CEO
Apr 18, 2022 10:58am
